Navigation Links
Elekta Demonstrates Commitment to Stereotactic Innovation at EANS

GLASGOW, Scotland, Sept. 3 /PRNewswire/ -- Leading neurosurgical device developer Elekta will feature the newest advances in neurosurgical diagnostic and treatment devices, along with clinical workflow solutions that make neurosurgery more effective and efficient at the European Association of Neurosurgical Societies (EANS) European Congress September 2-7, 2007. More than 1,000 neurosurgeons and related medical professionals will gather at the Scottish Exhibition & Conference Centre in Glasgow for the event.

(Logo: )

Leksell Gamma Knife(R) Perfexion(TM) highlighted

Positioned at the entrance of the exhibition hall, Elekta will feature Leksell Gamma Knife(R) Perfexion(TM), a quantum leap in stereotactic radiosurgery. The revolutionary patented design of the new Leksell Gamma Knife Perfexion collimator system dramatically expands treatment reach, simplifying the process of treating multiple tumors in the same session. Leksell Gamma Knife Perfexion provides better dosimetry performance than any other competitive radiosurgical system currently on the market and is estimated to increase the number of patients that can benefit from Gamma Knife surgery by up to 40 percent.

In addition, Gamma Knife(R) surgery is a radiosurgical procedure that is specifically well suited for the treatment of brain metastases.

"Leksell Gamma Knife Perfexion offers brain metastasis treatment in less time than other radiosurgical devices. Feedback from the first users in France, the United Kingdom and the United States has been overwhelmingly positive. Professor Jean Regis, La Timone Hospital in Marseilles has published that it is possible to treat four brain metastases eccentrically located (frontal anterior, far lateral and posterior fossa) in less than two hours," says Rolf Kjellstrom, Vice President of Sales and Marketing, Neuro & Stereotactic Solutions, Elekta. "It treats brain tumors very efficiently, and because the treatment is non-invasive, patient recovery time is nonexistent or dramatically reduced compared with invasive surgery."

David A. Larson, M.D., Ph.D., Radiation Oncologist and Co-Medical Director at the Gamma Knife Program, Washington Hospital, adds, "Our increasing ability to control primary cancers creates increased urgency to detect and treat metastatic lesions. Naturally, we want to do so non-invasively when possible and with a resulting positive impact on quality of life. Leksell Gamma Knife Perfexion, a remarkably sophisticated instrument, can safely and efficiently radiate multiple targets in a single session, and will surely benefit many patients."

New Linux-based software makes workflow more efficient and saves cost

Also on display will be Elekta neurosurgery workflow solutions, including Leksell SurgiPlan(R), Elekta's advanced image-based neurosurgical planning software, and GammaPlan(R) PFX(TM), a treatment planning system with remote capabilities that provides all the tools needed to make full use of the enhanced features of Leksell Gamma Knife Perfexion. Leksell SurgiPlan and Leksell GammaPlan are now Linux-based for more efficient workflow and lower cost to hospitals and clinics. Leksell SurgiPlan also has a new module for pre-planning, which enables flexible planning of procedures, and automatic optimization of image quality.

Elekta Neuromag(R) system provides real-time MEG brain mapping with high spatial resolution

Elekta also will be exhibiting Elekta Neuromag(R), an advanced device for performing magnetoencephalography (MEG). With a MEG system, neurosurgeons, neurologists and other specialists are able to non-invasively register nerve cell activity in the brain in real time. The technology is used routinely for pre-surgical mapping and epilepsy investigations as well as in clinical research. Elekta Neuromag features the highly innovative and unique MaxFilter(TM) software that filters all magnetic interferences and artefacts, providing an analysis with more reliable data.

Elekta Neuromag(R) 306 MEG channels sensor array has higher density than any other system on the market, providing a better representation of brain activity than any other MEG system.

MEG offers functional mapping information and measurement of brain activity in real time with high spatial resolution, unlike Computer Tomography (CT) and Magnetic Resonance Imaging (MRI and fMRI), which only provide structural, anatomical, metabolic and indirect functional information.

Elekta committed to advanced neurosurgery solutions

Elekta, known as the pioneer and world leader in stereotactic neurosurgery, continues to widen the gap between itself and other medical technology companies with the development of advanced tools for precision cancer treatment. "Elekta offers the complete spectrum of stereotactic devices," says Kjellstrom, "and Elekta's commitment to innovation in neurosurgery is unmatched."

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include, among others, Leksell Gamma Knife(R) product line for non-invasive treatment of brain disorders, Elekta Axesse(TM) for Image guided Stereotactic treatments, and Elekta Synergy(R) for intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world's largest supplier of oncology software.

Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approximately 2,000 employees, Elekta's corporate headquarters is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit

Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. Innovation featured in NE Wisconsin Roundtable
3. Changes to U.S. patent law must nurture our culture of innovation
4. Who is minding the Innovation Gap?
5. Abbott vs. Thailand has implications for innovation and access
6. Visions: Benson touts embedded innovation
7. UW System must remove barriers to innovation
8. Fusion 2007: Innovation drives productivity in post 24x7 world
9. In western Wisconsin, the innovation economy is growing
10. Scott Converse, UW-Madison School of Business, on the innovation mind-set
11. Innovation expert speaks on the business-IT balancing act
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
(Date:6/22/2016)... Research and Markets has announced the addition of the "Biomarkers: ... The global biomarkers market has grown ... market is expected to grow at a five-year compound annual growth ... billion in 2015 to $96.6 billion in 2020. ... 2020) are discussed. As well, new products approved in 2013 and ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):